Cleerly LABS vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly LABS

by Cleerly

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

Cleerly LABS focuses on the comprehensive analysis of coronary CT angiography to detect and characterize atherosclerosis and stenosis for heart disease management. In contrast, SensiCardiac Mobi assists in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. While both are FDA-cleared AI tools in cardiology, they address distinct diagnostic challenges using different data modalities, making them adjacent rather than direct competitors.

Choose Cleerly LABS if…

Choose Cleerly LABS if you require a comprehensive, non-invasive assessment of coronary artery disease, including detailed plaque characterization, stenosis quantification, and ischemia detection, to personalize patient management and track disease progression. This tool is ideal for clinicians seeking to visualize and quantify atherosclerosis using CCTA for precise risk stratification and treatment planning.

View Cleerly LABS →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an AI-powered mobile application to assist in the initial diagnosis and differentiation of heart murmurs during a physical examination. This tool is best suited for physicians who want to quickly analyze acoustic heart signals from an electronic stethoscope to distinguish between physiological and pathological sounds, guiding decisions for further cardiac investigation.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly LABS	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Per analysis	Contact for pricing
Deployment	Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cleerly LABS

Cleerly LABS (Tool A) is a web-based application, which typically offers a more expansive interface for detailed visualization and analysis of complex CCTA images. While SensiCardiac Mobi (Tool B) provides convenient mobile access, a web platform is generally more suitable for the comprehensive data review required for coronary plaque assessment. The need for a user-provided electronic stethoscope for Tool B also adds a potential setup hurdle.

Clinical Value

Cleerly LABS

Cleerly LABS (Tool A) offers a comprehensive and quantitative assessment of coronary atherosclerosis, including plaque characterization, stenosis quantification, and tracking disease progression over time, which is critical for personalized heart disease management and prevention. SensiCardiac Mobi (Tool B) provides valuable decision support for heart murmur diagnosis, but its scope is more focused on initial detection rather than the in-depth, longitudinal disease characterization offered by Tool A.

Pricing & Value

Cleerly LABS

Cleerly LABS (Tool A) provides transparent pricing information, detailing a per-analysis cost and outlining potential out-of-pocket expenses, allowing users to evaluate the financial commitment upfront. In contrast, SensiCardiac Mobi (Tool B) does not make its pricing publicly available, requiring direct contact for details, which hinders an immediate assessment of its value proposition.

Enterprise Readiness

Cleerly LABS

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), establishing a baseline for enterprise use. However, Cleerly LABS (Tool A) explicitly highlights its integration capabilities with PACS, RIS, and EHR systems via its Cleerly Proxy, which is crucial for seamless workflow integration within hospital and clinic environments. SensiCardiac Mobi (Tool B) does not detail similar integration features, which could be a barrier for broader enterprise adoption.

Innovation

Cleerly LABS

Cleerly LABS (Tool A) demonstrates significant innovation by moving beyond simple stenosis detection in CCTA to provide comprehensive plaque characterization, quantification, and tracking of disease progression, aiming to establish a new standard of care for heart attack prevention. While SensiCardiac Mobi (Tool B) innovatively applies AI to mobile auscultation for murmur diagnosis, Cleerly's depth of analysis and focus on long-term, personalized cardiovascular risk management represents a more transformative approach to a major health challenge.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information explicitly details the extent of support and documentation for either Cleerly LABS (Tool A) or SensiCardiac Mobi (Tool B). While Cleerly's website offers a 'Resources' section with educational content, specific user manuals, FAQs, or dedicated support channels are not clearly outlined for either product. Therefore, it is not possible to definitively distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly LABS	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Tool Name	Cleerly LABS	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Cleerly	DIACOUSTIC MEDICAL DEVICES (PTY)
Description	AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management.	FDA-cleared AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.
Primary Category	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Clinical Decision Support & Reference
Key Features	AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy	Acquires and records acoustic heart signals, Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm, Distinguishes between normal/physiological and pathological heart murmurs, Identifies S1, S2, and suspected murmurs, Records heart sounds at four main auscultation positions, Mobile application for data capture and display (e.g., iPhone 4S or later), Requires a compatible electronic stethoscope (user-provided), Operates as a decision support software, complementing physician assessment

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows and what specific clinical decisions do they support?

Cleerly LABS integrates into the radiology workflow for comprehensive CCTA analysis, providing detailed plaque assessment to guide personalized heart disease management and track disease progression. SensiCardiac Mobi fits into a physical exam workflow, offering immediate AI-powered decision support for differentiating physiological from pathological heart murmurs at the point of care.

What is the depth of EHR integration for each tool, and how does patient data flow between the system and the EHR?

Cleerly LABS integrates with PACS, RIS, and EHR systems via a Cleerly Proxy, facilitating comprehensive data transfer and streamlined access to results within existing clinical systems, including integration with radiology reporting solutions like PowerScribe. SensiCardiac Mobi operates as a mobile application for data capture and display, but the depth of direct EHR integration for automated result transfer is not explicitly detailed in the provided information.

How do the AI algorithms in each tool contribute to diagnostic accuracy and what are their specific strengths in identifying relevant clinical findings?

Cleerly LABS utilizes AI to accurately detect, quantify, and characterize coronary atherosclerosis and stenosis from CCTA images with high sensitivity and specificity, providing precise measurements of plaque volume and type. SensiCardiac Mobi employs an AI algorithm to analyze acoustic heart signals, specifically distinguishing between normal/physiological and pathological heart murmurs, and identifying S1, S2, and suspected murmurs.

What is the expected learning curve for physicians and staff, and what training or support is provided to ensure effective use?

Cleerly LABS, as a web-based imaging analysis tool providing comprehensive reports, likely has a moderate learning curve for interpreting detailed CCTA findings, with the company aiming to create a new standard of care. SensiCardiac Mobi, with its mobile application interface for stethoscope-acquired data and guided auscultation, is designed for ease of use at the point of care, suggesting a relatively quick learning curve.

What are the considerations for deploying each solution across multiple clinical sites or a larger healthcare system?

Cleerly LABS' cloud-based architecture with an on-site Cleerly Proxy suggests scalability for multi-site deployment, with the proxy being a pre-hardened virtual machine that can be installed and configured quickly. SensiCardiac Mobi, as a mobile application requiring a compatible electronic stethoscope, would primarily involve distributing the app and ensuring device compatibility across multiple locations.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly LABS or SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Backers

Who funded each tool's parent company.